CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $200,000 | -68.6% | 28,584 | -71.4% | 0.02% | -75.4% |
| Q1 2020 | $636,000 | -91.3% | 100,054 | +28.6% | 0.07% | -37.3% |
| Q2 2017 | $7,284,000 | +1256.4% | 77,800 | +177.9% | 0.11% | +323.1% |
| Q1 2016 | $537,000 | -90.6% | 28,000 | -55.1% | 0.03% | -94.0% |
| Q3 2015 | $5,738,000 | +2484.7% | 62,400 | +1980.0% | 0.43% | +1957.1% |
| Q1 2015 | $222,000 | -40.6% | 3,000 | -44.4% | 0.02% | +16.7% |
| Q1 2014 | $374,000 | +68.5% | 5,400 | +45.9% | 0.02% | -14.3% |
| Q4 2013 | $222,000 | – | 3,700 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 407,416 | $14,259,560,000 | 8.34% |
| Palo Alto Investors LP | 3,547,719 | $124,170,000 | 6.91% |
| Antipodean Advisors LLC | 1,268,658 | $44,403,000 | 6.48% |
| Redmile Group, LLC | 1,795,936 | $62,858,000 | 4.70% |
| HealthCor Management, L.P. | 1,525,000 | $53,375,000 | 3.24% |
| PointState Capital LP | 3,503,900 | $122,637,000 | 3.12% |
| NEA Management Company, LLC | 1,139,890 | $39,896,000 | 2.54% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 612,500 | $21,438,000 | 2.44% |
| PFM Health Sciences, LP | 2,078,440 | $72,745,000 | 2.21% |
| Partner Investment Management, L.P. | 35,300 | $1,236,000 | 2.03% |